Position in FTRE
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,165,621
-$968,876 QoQ
Shares Held
123,739
0.0% QoQ
Ownership
0.131%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026INTRUST BANK NA holds $7,434,440 across 12 Biotechnology names. FTRE ranks #2 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,902 | $1,742,398 | |
| 2 | FTRE |
Fortrea Holdings Inc.
This page
|
123,739 | $1,165,621 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
4,508 | $761,941 | |
| 4 | ARGX |
Argenx SE
|
943 | $688,625 | |
| 5 | INSM |
INSMED Inc
|
3,518 | $575,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
623 | $481,354 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
863 | $451,754 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
6,942 | $448,661 |
All Filings in FTRE
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,165,621 | 123,739 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,134,497 | 123,739 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,041,881 | 123,739 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $611,274 | 123,740 | Shares | Sole | 2025-08-11 | |
| No filing history on record for this holder in this stock. | ||||||